Page 26 - Genentech News Today

Biotech stocks offers the potential for significant returns driven by breakthrough discoveries and advancements in healthcare, agriculture, and other industries.

Researchers at Stanford say a newly approved drug treatment could change the lives of millions of children with food allergies.

Investors have pumped more than $191 million into the young companies since the start of the competition six years ago. 

Digital Medicine Academy® supports the extension launch with new V3+ Crash Course

The data follow the FDA approval of omalizumab for the reduction of allergic reactions, including anaphylaxis, that can occur after exposure to 1 or more foods.

NVIDIA today announced it will host its flagship GTC 2024 conference at the San Jose Convention Center from March 18-21. More than 300,000 p...

Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and...

A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods.

Medication reduces potentially deadly reactions to allergy-triggering foods like nuts, milk and wheat.

The FDA expanded approval for the asthma drug Xolair for multiple food allergies including peanuts and tree nuts to reduce reactions from accidental exposures.